ZCM
VIVO

Zebra Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Zebra Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-67,738
Closed -$1.58M – 299
2020
Q2 		$1.58M Sell
67,738
-15,777
-19% -$229K 2.28% 2
2020
Q1 		$701K Sell
83,515
-8,241
-9% -$69.4K 1.13% 7
2019
Q4 		$896K Buy
91,756
+67,090
+272% +$630K 0.8% 19
2019
Q3 		$235K Buy
24,666
+14,611
+145% +$154K 0.26% 151
2019
Q2 		$119K Sell
10,055
-1,845
-16% -$22.2K 0.06% 432
2019
Q1 		$210K Buy
+11,900
New +$198K 0.11% 378
2017
Q2 		– Sell
-23,305
Closed -$322K – 294
2017
Q1 		$322K Sell
23,305
-13,610
-37% -$190K 0.1% 247
2016
Q4 		$653K Buy
36,915
+2,083
+6% +$36.6K 0.2% 201
2016
Q3 		$672K Buy
34,832
+5,279
+18% +$103K 0.21% 211
2016
Q2 		$576K Buy
29,553
+4,655
+19% +$91.3K 0.2% 215
2016
Q1 		$513K Buy
24,898
+4,802
+24% +$94.6K 0.2% 207
2015
Q4 		$412K Buy
20,096
+1,285
+7% +$24.6K 0.23% 196
2015
Q3 		$322K Buy
18,811
+188
+1% +$3.44K 0.2% 212
2015
Q2 		$347K Sell
18,623
-2,152
-10% -$39.9K 0.2% 206
2015
Q1 		$396K Sell
20,775
-766
-4% -$14.2K 0.2% 192
2014
Q4 		$355K Buy
21,541
+592
+3% +$10.2K 0.14% 222
2014
Q3 		$371K Buy
20,949
+682
+3% +$13.4K 0.15% 221
2014
Q2 		$418K Buy
20,267
+3,621
+22% +$74.4K 0.16% 215
2014
Q1 		$363K Buy
16,646
+4,320
+35% +$99K 0.15% 233
2013
Q4 		$327K Buy
12,326
+2,884
+31% +$70.9K 0.17% 195
2013
Q3 		$223K Buy
+9,442
New +$220K 0.17% 201

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Zebra Capital Management's VIVO Position: Q3 2020 in Review

Zebra Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2020, closing a stake of 67,738 shares — an estimated $1.58M sold.

Zebra Capital Management first reported a position in VIVO in Q3 2013 and held it in 21 quarters. The position peaked at $1.58M in Q2 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q3 2020.

  • Zebra Capital Management reported no remaining Meridian Bioscience Inc position as of Q3 2020 after selling out during the quarter.
  • Zebra Capital Management sold 67,738 Meridian Bioscience Inc shares in Q3 2020, an estimated $1.58M.
  • Zebra Capital Management first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 21 quarters.
  • Zebra Capital Management's Meridian Bioscience Inc position peaked at $1.58M in Q2 2020.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2020.

Based on Zebra Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.